Fingolimod sensitizes EGFR wild‑type non‑small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 135
(4)
◽
pp. 2728-2735
◽
Keyword(s):
2013 ◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 519
(4)
◽
pp. 846-853
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 46
(3)
◽
pp. 1039-1050
Keyword(s):
Keyword(s):